According to the most recent analysis by Emergen Research, the global Endoscopic Retrograde Cholangiopancreatography (ERCP) market size was USD 1.25 billion in 2021 and is anticipated to grow at a revenue CAGR of 9.6% during the projected period. In order to advance endoscopy research, governments and healthcare organisations are increasing their investments and grants. Hospitals are focusing more on investing in advanced endoscopy instruments, patients are favouring minimally invasive surgeries, and single-use endoscopy instruments are becoming more widely used.
Endoscopy is a medical procedure used to do some small surgery or to closely examine bodily tissue or internal organs. Devices for endoscopic retrograde cholangiopancreatography (ERCP) are medical tools made for conditions relating to the pancreas and biliary system. Due to an increase in the prevalence of various bile duct, pancreatic, and liver disorders like Barrett’s disease, biliary disease, colitis, Crohn’s disease, gastroesophageal reflux disorder (GERD), liver disease, pancreatitis, inflammatory bowel disease, Crohn’s disease, and peptic ulcer disease, these devices are becoming more and more important and being used more frequently.
The COVID-19 epidemic has significantly impacted endoscopic services on a global scale. Furthermore, touch and droplets are used to spread the illness. Because the spread of the pandemic is primarily by direct touch or aerosol droplets and endoscopic procedures necessitate a close physical proximity between patients and staff, endoscopy healthcare practitioners are at extremely high risk during the pandemic. Based on their experience with SARS, Hong Kong reported that doctors have a 5% infection risk, nurses have a 4% risk, and healthcare assistants have an 8% risk. It underlined the significance of adhering to the usage of personal protective equipment, infection control procedures, and stringent isolation practises (PPE). Therefore, the COVID-19 pandemic has a detrimental effect on the market for endoscopic retrograde cholangiopancreatography.
Request a sample copy of the report @ https://www.emergenresearch.com/request-sample/1441
The increase in gastrointestinal and chronic biliary disorders like Barrett’s disease, biliary disease, colitis, Crohn’s disease, gastroesophageal reflux disorder (GERD), liver disease, pancreatitis, inflammatory bowel disease, and peptic ulcer disease is a major factor driving the growth of the global endoscopic retrograde cholangiopancreatography (ERCP) market. Along with this, there is a rapid rise in the frequency of benign tumours of the pancreas and liver, an ageing population, and increased public awareness of the ERCP devices used to treat illnesses. Endoscopic retrograde cholangiopancreatography market expansion is anticipated to be constrained by high treatment costs associated with ERCP and its adverse effects, such as post-ERCP pancreatitis. On the other hand, emerging nations have a significant potential for growth due to the development of their healthcare systems.
Drivers: Rising incidence of cancer
During the forecast period, the endotherapy devices segment held the biggest market share by product type.
Driving factors including the rise in less invasive operations and the incidence of gastrointestinal diseases are to blame for this.
Sphincterotomes held the highest share of the endotherapy device market over the forecasted period.
Stones in the bile duct and pancreatic duct are becoming more common, and the number of elderly people is rising (and therefore, an increase in biliary disorders).
Purchase this report at an exclusively discounted rate @ https://www.emergenresearch.com/request-discount/1441
Possibilities include the expanding healthcare industry in emerging economies.
The BRICS countries—Brazil, Russia, India, China, and South Africa—have some of the world’s fastest-growing economies. The emerging economies were responsible for around one-third of global healthcare spending in 2021, according to the World Economic Forum. Due to the fact that China and India have the largest populations in the world, these nations also have the most patients.
Players in the endoscopy equipment market are encouraged to increase their presence in emerging nations by the rising incidence of cancer, quick advancements in healthcare infrastructure, the rapid expansion of medical tourism, and the presence of flexible regulation in these nations.
The Asia Pacific, the Middle East, and Latin America are now seeing a rise in the number of endoscopic equipment manufacturers setting up shop there. Important companies have already established their manufacturing and R&D centres in these nations, such KARL STORZ. Additionally, producers will be forced to concentrate on emerging markets in the upcoming years due to market saturation in developed regions like North America and Europe.
These elements are anticipated to present the ERCP market with sizable potential opportunities.
Review of the application segment
Due to an increase in the occurrence of obstructive ductal calculi, ductal disruption & leak, sphincter stenosis, and dominant pancreatic stricture, the pancreatic sphincterotomy segment is anticipated to experience the greatest CAGR during the projection period. The market for endoscopic retrograde cholangiopancreatography is also expanding as a result of the surge in demand for endoscopic procedures used to treat a variety of pancreatic and pancreas-related illnesses.
Request customization of the report @ https://www.emergenresearch.com/request-for-customization/1441
Emergen Research has segmented the global endoscopic retrograde cholangiopancreatography market based on product, procedure, end-use, and region:
- Product Outlook (Revenue, USD Billion; 2019-2030)
- Endoscopes
- Endotherapy Devices
- Visualization Systems
- Energy Devices
- Others
- Procedure Outlook (Revenue, USD Billion; 2019-2030)
- Biliary Sphincterotomy
- Biliary Dilation
- Biliary Stenting
- Pancreatic Sphincterotomy
- Pancreatic Duct Dilation
- Pancreatic Duct Stenting
- End-use Outlook (Revenue, USD Billion; 2019-2030)
- Hospitals & Clinics
- Ambulatory Surgical Centers
- Others
- Regional Outlook (Revenue, USD Billion; 2019-2030)
- North America
- U.S.
- Canada
- Mexico
- Europe
- Germany
- France
- UK
- Italy
- Spain
- Benelux
- Rest of Europe
- Asia Pacific
- China
- India
- Japan
- South Korea
- Rest of APAC
- Latin America
- Brazil
- Rest of LATAM
- Middle East & Africa
- Saudi Arabia
- UAE
- South Africa
- Turkey
- Rest of Middle East & Africa
- North America
To know more about the report, visit @ https://www.emergenresearch.com/industry-report/endoscopic-retrograde-cholangiopancreatography-market
Principal Gains for Stakeholders
- To identify the present prospects and make a strategic assessment, this study includes a thorough quantitative analysis of the current global endoscopic retrograde cholangiopancreatography market trends from 2021 to 2030.
- From 2021 to 2030, the endoscopic retrograde cholangiopancreatography market forecast is examined.
- The endoscopic retrograde cholangiopancreatography market size and estimates are based on a thorough examination of significant advancements in the sector.
- The development tactics implemented by the top market players are included to comprehend the competitive scenario of the endoscopic retrograde cholangiopancreatography market.
- A qualitative analysis based on novel goods aids strategic business planning.
Thank you for reading our report. For any specific details on customization of this report, please get in touch with us. We will ensure the report you get is well-suited to your needs.
Explore More Emergen Research Reports @
Prefilled Syringes Market
https://www.emergenresearch.com/industry-report/prefilled-syringes-market
Artificial Intelligence In Radiology Market
https://www.emergenresearch.com/industry-report/artificial-intelligence-in-radiology-market
Gut Microbiome Test Market
https://www.emergenresearch.com/industry-report/gut-microbiome-test-market
Human Microbiome Market
https://www.emergenresearch.com/industry-report/human-microbiome-market
Molecular Forensics Market
https://www.emergenresearch.com/industry-report/molecular-forensics-market
Mobile C-Arms Market
https://www.emergenresearch.com/industry-report/mobile-c-arms-market
Surgical Instrument Tracking Systems Market
https://www.emergenresearch.com/industry-report/surgical-instrument-tracking-systems-market
Tissue Imaging Market
https://www.emergenresearch.com/industry-report/tissue-imaging-market
Gerd Drugs And Devices Market
https://www.emergenresearch.com/industry-report/gerd-drugs-and-devices-market
Occlusion Devices Market
https://www.emergenresearch.com/industry-report/occlusion-devices-market
About Emergen Research
At Emergen Research, we believe in advancing with technology. We are a growing Marketresearch and strategy consulting company with an exhaustive knowledge base of cutting-edge and potentially market-disrupting technologies that are predicted to become more prevalent in the coming decade.
Contact Us:
Eric Lee
Corporate Sales Specialist
Emergen Research | Web: www.emergenresearch.com
Direct Line: +1 (604) 757-9756
E-mail: sales@emergenresearch.com
Facebook | LinkedIn | Twitter | Blogs
Visit for More Insights: https://www.emergenresearch.com/insights
Explore Our Custom Intelligence services | Growth Consulting Services